AVAVA
Colin Sloan is an experienced quality management professional with a background in various roles within the medical and biosystems industries. Currently serving as a Quality Manager at AVAVA since March 2024 and as a Quality Operations Manager at Cytrellis Biosystems, Inc. since January 2023, Colin has previously held positions including Quality Manager at Respiratory Motion and Senior Quality Assurance Specialist at Nova Biomedical. Colin's career also includes significant experience as a Quality Assurance Manager at Stryker and Mobius Imaging, LLC, and earlier work as a Quality Systems Specialist at Keystone Dental Inc. Colin holds a Bachelor of Science degree in Sports Management from the University of Massachusetts Amherst, earned between 2002 and 2006.
This person is not in any teams
AVAVA
AVAVA™ developed a new class of FDA-cleared, non-invasive aesthetic medical devices with patented precision technology to provide best in class patient and provider experience for all skin tones. The AVAVA proprietary Focal Point Technology™ is complemented by AVAVASite, a high-resolution interactive imaging system, which provides treatment intelligence to map and guide real-time therapy with actionable data, to unlock safe and effective treatments. AVAVA received FDA Clearance 510(k) for its first two devices in 2022, the first of which, MIRIA™ will have a limited release in 2023 with broad scale commercial availability in 2024. The MIRIA System is a high energy focused intradermal laser, powered by Focal Point Technology™, that delivers energy at any depth in the skin with pinpoint accuracy, making it ideal for patients with darker skin tones. The MIRIA System delivers a high dose of conical energy to the dermis and spares the sensitive epidermis from unwanted damage — all while maintaining patient comfort and with minimal downtime. Extensive MIRIA clinical studies have demonstrated improvement in all signs of skin aging, including wrinkles, sun damage, and skin quality, as well as reduction in pitted acne scarring and large pore size across a wide range of skin types and colors. The MIRIA by AVAVA System™ will help address the needs of over 11.7 million US-individuals of all skin tones that seek facial rejuvenation each year.